Sort
51,593 grants matching “hepatitis”
Mechanism of poliovirus replication
$384,081Raul Andino · University Of California, San Francisco · R01 · FY2014 · AI
Immunogenetic Mechanisms of Vaccine Response
$384,066Gregory A. Poland · Mayo Clinic Rochester · R01 · FY2010 · AI
Hepatitis C virus escape mechanisms from innate immunity
$384,027Ranjit Ray · Washington University · U54 · FY2011 · AI
Silencing of HIV-1 proviruses by epigenetically targeting transcriptional elongation
$384,023Qin Feng · University Of Houston · R61 · FY2019 · AI
Effects of miR-30c deficiency on plasma cholesterol and atherosclerosis
$384,000M Mahmood Hussain · Nyu Winthrop Hospital · R01 · FY2018 · HL
PROTEASE INHIBITOR-INDUCED HYPERLIPIDEMIA IN AIDS
$384,000Emory University · R01 · FY2004 · HL
Effects of miR-30c deficiency on plasma cholesterol and atherosclerosis
$384,000M Mahmood Hussain · Nyu Winthrop Hospital · R01 · FY2019 · HL
Effects of miR-30c deficiency on plasma cholesterol and atherosclerosis
$384,000M Mahmood Hussain · Nyu Winthrop Hospital · R01 · FY2017 · HL
PROTEASE INHIBITOR-INDUCED HYPERLIPIDEMIA IN AIDS
$384,000Emory University · R01 · FY2003 · HL
PROTEASE INHIBITOR-INDUCED HYPERLIPIDEMIA IN AIDS
$384,000Emory University · R01 · FY2002 · HL
PROTEASE INHIBITOR-INDUCED HYPERLIPIDEMIA IN AIDS
$384,000Emory University · R01 · FY2001 · HL
PROTEASE INHIBITOR-INDUCED HYPERLIPIDEMIA IN AIDS
$384,000Emory University · R01 · FY2000 · HL
Cell-cell adhesion-mediated signaling determines epithelial polarization in the liver
$384,000Anne Muesch · Albert Einstein College Of Medicine · R01 · FY2024 · DK
ROLE OF DGAT IN TRIACYLGLYCEROL METABOLISM
$383,963J. David Gladstone Institutes · R01 · FY2000 · DK
Alcoholic Hepatitis Clinical and Translational Network Late Phase Clinical Trials and Observational Studies 6/9
$383,958Srinivasan Dasarathy · Cleveland Clinic Lerner Com-Cwru · U01 · FY2020 · AA
Using human liver tissue equivalents to optimize AAV-mediated GT and better define age-related clinical risks
$383,921Graca Duarte Almeida-Porada · Wake Forest University Health Sciences · R01 · FY2024 · HL
Broad Spectrum Treatment of Hemmorrhagic Arenaviruses
$383,917Philip E Thorpe · Ut Southwestern Medical Center · U01 · FY2010 · AI
IMMUNOTHERAPY PROTECTION &VACCINES FOR HEPATITIS C
$383,896Rockefeller University · R01 · FY2001 · CA
Development of epidermal progenitor cell-based therapy for regenerative medicine
$383,860Xiaoyang Wu · University Of Chicago · R01 · FY2017 · OD
Pure Flavonolignans from S. marianum in Prostate Cancer
$383,850David J Kroll · Research Triangle Institute · R01 · FY2006 · CA
TNF Alpha and Recovery from Alchoholic Liver Injury
$383,838Anna Mae Elizabeth Diehl · Duke University · R37 · FY2009 · AA
P3 - Effect of ZCM microbicide on HIV, HSV-2, HBV, C. trachomatis & T. Vaginalis
$383,833David Phillips · Population Council · U19 · FY2009 · AI
Using human liver tissue equivalents to optimize AAV-mediated GT and better define age-related clinical risks
$383,800Graca Duarte Almeida-Porada · Wake Forest University Health Sciences · R01 · FY2025 · HL
Effects of periodontitis on insulin target organs and glucose homeostasis
$383,782Keiko Watanabe · University Of Illinois At Chicago · R01 · FY2012 · DE
Community-based Hep B Intervention for Hmong Adults
$383,782Moon S Chen · University Of California At Davis · P01 · FY2007 · CA